Personalized medicine — Impasse or inflection point?

Systemic inequities, an uncertain regulatory and reimbursement outlook for diagnostic tests, and lingering questions about access, affordability, and costs impact the pace at which groundbreaking personalized therapies become available to patients. The 14th Annual Personalized Medicine Conference at Harvard Medical School will explore how these and other trends shape the outlook for personalized medicine. Register today.